The Food and Drug Administration (FDA) announced a public advisory committee meeting of the Anesthetic and Analgesic Drug Products Advisory Committee. This meeting, scheduled for January 10, 2025, is open to the public and can be attended either in person at the FDA campus in Silver Spring, MD, or online. The meeting will discuss the Biologics License Application for condoliase injection, aimed at treating radicular leg pain associated with lumbar disc herniation. The FDA is also accepting public comments on this topic until January 9, 2025, and encourages individuals to submit their views electronically or via written submissions.
Simple Explanation
The FDA is having a meeting where people will talk about a new medicine that might help with back pain, and anyone can join or share their thoughts about it. They want to make sure everyone knows how to join the meeting and share their ideas, but some of the instructions are a bit hard to understand.